The Bayhep B market is witnessing steady growth over the forecast period, supported by growth in liver transplant procedures, increasing hepatitis screening rates.
Read More
The Baygam market is witnessing steady growth over the forecast period, supported by increasing animal bite incidents, expansion of vaccination programs.
Read More
The Bavencio (Avelumab) market is witnessing steady growth over the forecast period, supported by expansion into new tumor indications, increasing global immunotherapy adoption.
Read More
The BAT (Botulism Antitoxin Heptavalent) market is witnessing steady growth over the forecast period, supported by rising biodefense investments, growth in national stockpile programs.
Read More
The Basaglar market is witnessing steady growth over the forecast period, supported by continued growth in diabetic population, biosimilar substitution policies.
Read More
The Balfaxar market is witnessing steady growth over the forecast period, supported by increase in elderly patient surgeries, rising anticoagulant usage.
Read More
The BabyBIG market is witnessing steady growth over the forecast period, supported by improved surveillance of infant botulism, continued public health funding.
Read More
The Avonex market is witnessing steady growth over the forecast period, supported by expansion of ms patient population, demand for stable long-term therapies.
Read More
The Avastin (Bevacizumab) market is witnessing steady growth over the forecast period, supported by growth of bevacizumab biosimilars, expanding oncology patient pool.
Read More
The Autoplex market is witnessing steady growth over the forecast period, supported by growth in diagnosed inhibitor patients, expansion of specialty bleeding centers.
Read More